Insights into Androgen Receptor Action in Lung Cancer
Endocrines · 03.04.2023 · 4 (2) · 269-280
DOI: 10.3390/endocrines4020022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrines, online erschienen am 03.04.2023. Verfasst von Darko Durovski und 2 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Alpe d’Huzes/KWF Bas Mulder Award, the Ministry for Science and Technological Development of the Republic of Serbia.
Abstract (Originalsprache)
Sex hormones and their receptors play a crucial role in human sexual dimorphism and have been traditionally associated with hormone-dependent cancers like breast, prostate, and endometrial cancer. However, recent research has broadened our understanding by revealing connections with other types of cancers, such as lung cancer, where the androgen receptor has been found to be particularly significant. This review aims to explore the molecular mechanisms of androgen action in lung cancer pathogenesis and progression, highlighting the potential of inhibiting the androgen receptor signaling pathway as a therapeutic strategy for lung cancer treatment.
Förderung
- the Alpe d’Huzes/KWF Bas Mulder Award
- the Ministry for Science and Technological Development of the Republic of Serbia
Zitieren
APA
Durovski, D., Jankovic, M., & Prekovic, S. (2023). Insights into Androgen Receptor Action in Lung Cancer. Endocrines, 4(2), 269-280. https://doi.org/10.3390/endocrines4020022
Vancouver
Durovski D, Jankovic M, Prekovic S. Insights into Androgen Receptor Action in Lung Cancer. Endocrines. 2023;4(2):269-280. doi:10.3390/endocrines4020022
BibTeX
@article{Durovski2023,
author = {Durovski, Darko and Jankovic, Milica and Prekovic, Stefan},
title = {Insights into Androgen Receptor Action in Lung Cancer},
journal = {Endocrines},
year = {2023},
volume = {4},
number = {2},
pages = {269--280},
doi = {10.3390/endocrines4020022}
}
EUVIMED